StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
AstraZeneca (AZN) to Acquire ZS Pharma (ZSPH) in $2.7B Deal
November 6, 2015 6:36 AM
AstraZeneca (NYSE: AZN) announced today that it has entered into a definitive agreement to acquire ZS Pharma (NASDAQ: ZSPH), a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Conference Calls
Corporate News
Hot Corp. News
Management Comments
Mergers and Acquisitions
Next Articles
AstraZeneca (AZN) Reports In-Line 3Q; Leerink Partners Reiterates Market Perform
November 9, 2015 9:36 AM
JPMorgan Downgrades ZS Pharma (ZSPH) to Neutral
November 9, 2015 7:17 AM
Morgan Stanley Downgrades ZS Pharma (ZSPH) to Equalweight
November 9, 2015 7:16 AM
Credit Suisse Downgrades ZS Pharma (ZSPH) to Neutral on Takeover
November 9, 2015 6:24 AM
William Blair Downgrades ZS Pharma (ZSPH) to Market Perform
November 6, 2015 2:23 PM
Relypsa (RLYP) Poised to Open Higher Following AstraZeneca (AZN)/ZS Pharma (ZSPH) Deal
November 6, 2015 6:53 AM
Form 8-K ZS Pharma, Inc. For: Nov 05
November 6, 2015 6:07 AM
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion
November 6, 2015 2:19 AM
